AAAAAA

   
Results: 1-18 |
Results: 18
LIPID DISORDERS AND CARDIOVASCULAR RISKS IN NEPHROLOGY
Authors: DAIROU F
Citation: F. Dairou, LIPID DISORDERS AND CARDIOVASCULAR RISKS IN NEPHROLOGY, Nephrology, dialysis, transplantation, 13, 1998, pp. 30-33
SURVIVAL AND CARDIOVASCULAR-DISEASE IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES FOR FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LDL-APHERESIS
Authors: BENLIAN P DEGENNES JL DAIROU F ASSOGBA U TURPIN G BERNARD C BERTRAND V BEREZIAT G
Citation: P. Benlian et al., SURVIVAL AND CARDIOVASCULAR-DISEASE IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES FOR FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LDL-APHERESIS, Atherosclerosis, 134(1-2), 1997, pp. 42-42
LDL APHERESIS WITH HEMOPERFUSION SYSTEM DALI(R)
Authors: ASSOGBA U DAIROU F BEGHDADI M HAZIZA A BRUCKERT E FOURNEI JJ TURPIN G
Citation: U. Assogba et al., LDL APHERESIS WITH HEMOPERFUSION SYSTEM DALI(R), Atherosclerosis, 134(1-2), 1997, pp. 53-53
LONG-TERM SURVIVAL IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES FOR FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LDL-APHERESIS
Authors: BENLIAN P DEGENNES JL DAIROU F ASSOGBA U BERTRAND V BERNARD C BEREZIAT G
Citation: P. Benlian et al., LONG-TERM SURVIVAL IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES FOR FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LDL-APHERESIS, Circulation, 96(8), 1997, pp. 4121-4121
PHENOTYPIC-EXPRESSION IN DOUBLE HETEROZYGOTES FOR FAMILIAL HYPERCHOLESTEROLEMIA AND FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100
Authors: BENLIAN P DEGENNES JL DAIROU F HERMELIN B GINON I VILLAIN E LAGARDE JP FEDERSPIEL MC BERTRAND V BERNARD C BEREZIAT G
Citation: P. Benlian et al., PHENOTYPIC-EXPRESSION IN DOUBLE HETEROZYGOTES FOR FAMILIAL HYPERCHOLESTEROLEMIA AND FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100, Human mutation, 7(4), 1996, pp. 340-345
LACK OF ASSOCIATION BETWEEN CORNEAL ARCUS AND PLASMA-CONCENTRATION OFLIPOPROTEIN (A) IN HYPERLIPIDEMIC SUBJECTS
Authors: KIORTSIS D BRUCKERT E GIRAL P DAIROU F TURPIN G
Citation: D. Kiortsis et al., LACK OF ASSOCIATION BETWEEN CORNEAL ARCUS AND PLASMA-CONCENTRATION OFLIPOPROTEIN (A) IN HYPERLIPIDEMIC SUBJECTS, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 6(4), 1996, pp. 234-238
EFFECTS OF RILMENIDINE (HYPERIUM) ON THE LIPID BALANCE OF HYPERLIPIDEMIC HYPERTENSIVE PATIENTS - RANDOMIZED, CONTROLLED, DOUBLE-BLIND 8-WEEK STUDY IN PARALLEL GROUPS VERSUS CAPTOPRIL
Authors: SCEMAMA M FEVRIER B BEUCLER I DAIROU F
Citation: M. Scemama et al., EFFECTS OF RILMENIDINE (HYPERIUM) ON THE LIPID BALANCE OF HYPERLIPIDEMIC HYPERTENSIVE PATIENTS - RANDOMIZED, CONTROLLED, DOUBLE-BLIND 8-WEEK STUDY IN PARALLEL GROUPS VERSUS CAPTOPRIL, Annales de cardiologie et d'angeiologie, 45(10), 1996, pp. 595-601
LIPOPROTEIN GLOMERULOPATHY - FIRST CASE IN A WHITE EUROPEAN
Authors: MEYRIER A DAIROU F CALLARD P MOUGENOT B
Citation: A. Meyrier et al., LIPOPROTEIN GLOMERULOPATHY - FIRST CASE IN A WHITE EUROPEAN, Nephrology, dialysis, transplantation, 10(4), 1995, pp. 546-549
METASTATIC LUNG-CANCER INITIALLY PRESENTI NG AS CUSHINGS-SYNDROME OF PITUITARY ORIGIN - 25 YEAR FOLLOW-UP
Authors: DEGENNES JL KIORTSIS DN DAIROU F BERTAGNA X MALINSKY M
Citation: Jl. Degennes et al., METASTATIC LUNG-CANCER INITIALLY PRESENTI NG AS CUSHINGS-SYNDROME OF PITUITARY ORIGIN - 25 YEAR FOLLOW-UP, La Presse medicale, 24(34), 1995, pp. 1605-1607
CARING FOR PATIENTS WITH DYSLIPIDEMIA
Authors: BRUCKERT E DAIROU F TURPIN G
Citation: E. Bruckert et al., CARING FOR PATIENTS WITH DYSLIPIDEMIA, La Presse medicale, 24(25), 1995, pp. 1147-1151
HORMONE SUBSTITUTION IN POSTMENOPAUSE
Authors: TURPIN G BRUCKERT E DAIROU F
Citation: G. Turpin et al., HORMONE SUBSTITUTION IN POSTMENOPAUSE, La Presse medicale, 24(19), 1995, pp. 905-909
LIPID PROFILE AND ANTIHYPERTENSIVE EFFICACY IN HYPERLIPIDEMIC HYPERTENSIVE PATIENTS - COMPARISON OF RILMENIDINE AND CAPTOPRIL
Authors: SCEMAMA M FEVRIER B BEUCLER I DAIROU F
Citation: M. Scemama et al., LIPID PROFILE AND ANTIHYPERTENSIVE EFFICACY IN HYPERLIPIDEMIC HYPERTENSIVE PATIENTS - COMPARISON OF RILMENIDINE AND CAPTOPRIL, Journal of cardiovascular pharmacology, 26, 1995, pp. 34-39
BLOOD ANTIOXIDANTS (VITAMIN-E AND BETA-CAROTENE) IN LONG-TERM LOW-DENSITY-LIPOPROTEIN APHERESIS
Authors: ASSOGBA U LEPAGE S BRUCKERT E BONNEFONTROUSSELOT D DAIROU F DEGENNES JL DELATTRE J
Citation: U. Assogba et al., BLOOD ANTIOXIDANTS (VITAMIN-E AND BETA-CAROTENE) IN LONG-TERM LOW-DENSITY-LIPOPROTEIN APHERESIS, Clinica chimica acta, 235(2), 1995, pp. 147-157
HYPERCHOLESTEROLEMIA-LOWERING STATINS - A SSESSMENT AND PROSPECTS
Authors: DAIROU F
Citation: F. Dairou, HYPERCHOLESTEROLEMIA-LOWERING STATINS - A SSESSMENT AND PROSPECTS, La Presse medicale, 23(28), 1994, pp. 1304-1310
LAPAROSCOPIC EXERESIS OF A FORTUITOUSLY I DENTIFIED PHEOCHROMOCYTOMA
Authors: TURPIN G CHIGOT JP FOUBERT L MOVSCHIN M BENSIMON C BRUCKERT E DAIROU F
Citation: G. Turpin et al., LAPAROSCOPIC EXERESIS OF A FORTUITOUSLY I DENTIFIED PHEOCHROMOCYTOMA, La Presse medicale, 23(20), 1994, pp. 951-951
SELENIUM DEFICIENCY IN HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH LDLAPHERESIS
Authors: JAUDON MC ASSOGBA U BOURELY B DAIROU F BRUCKERT E DELATTRE J
Citation: Mc. Jaudon et al., SELENIUM DEFICIENCY IN HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH LDLAPHERESIS, Lancet, 343(8906), 1994, pp. 1160-1160
EFFECTIVENESS OF LDL APHERESIS IN SEVERE HYPERCHOLESTEROLEMIA
Authors: DAIROU F ASSOGBA U BRUCKERT E DEGENNES JL TURPIN G
Citation: F. Dairou et al., EFFECTIVENESS OF LDL APHERESIS IN SEVERE HYPERCHOLESTEROLEMIA, Annales de medecine interne, 145(5), 1994, pp. 328-332
MOLECULAR-GENETICS OF PURE PRIMARY HYPERC HOLESTEROLEMIA
Authors: BENLIAN P DAIROU F DEGENNES JL
Citation: P. Benlian et al., MOLECULAR-GENETICS OF PURE PRIMARY HYPERC HOLESTEROLEMIA, Bulletin de l'Academie nationale de medecine, 178(3), 1994, pp. 393-403
Risultati: 1-18 |